Appendicitis News and Research RSS Feed - Appendicitis News and Research

Appendicitis is a painful swelling and infection of the appendix. The appendix is a fingerlike pouch attached to the large intestine and located in the lower right area of the abdomen. Scientists are not sure what the appendix does, if anything, but removing it does not appear to affect a person’s health. The inside of the appendix is called the appendiceal lumen. Mucus created by the appendix travels through the appendiceal lumen and empties into the large intestine.
Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis reports positive results from ceftazidime-avibactam Phase III studies in cIAI patients

Actavis plc today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections. [More]
New algorithm eliminates exposure to radiation when diagnosing children with acute appendicitis

New algorithm eliminates exposure to radiation when diagnosing children with acute appendicitis

Implementation of an algorithm aimed to diagnose pediatric patients with suspected appendicitis reduces the utilization of computed tomography (CT) scans, without affecting diagnostic accuracy, Mayo Clinic Children's Center researchers have found. The study was recently published in the journal Surgery. [More]
Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Antibiotics present a safe option for treating children with uncomplicated acute appendicitis

Using antibiotics alone to treat children with uncomplicated acute appendicitis is a reasonable alternative to surgery that leads to less pain and fewer missed school days, according to a pilot study. [More]
Venaxis files 510(k) premarket submission with FDA for APPY1 Test

Venaxis files 510(k) premarket submission with FDA for APPY1 Test

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™ Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis has requested concurrent de novo determination and 510(k) clearance from the U.S. Food and Drug Administration. [More]
Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Venaxis' APPY1 Test for appendicitis shows positive results in pivotal U.S. study

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced positive top-line results from its pivotal U.S. study. [More]

NYSS affiliates with International Journal of Surgery to access important research

The New York Surgical Society (NYSS) has decided to affiliate with the International Journal of Surgery in an agreement that gives members of the Society easy access to the important research published by the journal and marks the growth in the journal's international reach. [More]
Portable ultrasound for kids with suspected appendicitis reduces emergency room length of stay

Portable ultrasound for kids with suspected appendicitis reduces emergency room length of stay

Using portable ultrasound as a first-line imaging study in kids with suspected appendicitis helps reduce emergency room length of stay and reduces the need for CT scans, according to a team of Mount Sinai researchers. [More]
Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). [More]
Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States. [More]
New classification system to manage emergency surgery described in special issue of  BJS

New classification system to manage emergency surgery described in special issue of BJS

Researchers in Finland have implemented a classification system for emergency operations that allows for a fair and efficient way to manage a large volume of such surgery. [More]
Antibiotic resistance holds stable in U.S. children's hospitals

Antibiotic resistance holds stable in U.S. children's hospitals

Two studies published in the December issue of Infection Control and Hospital Epidemiology show antibiotic resistance patterns for children have held stable over a seven-year period and surgical patients in U.S. children's hospitals account for 43 percent of all antibiotic use in children's hospitals, presenting an opportunity for targeted intervention. [More]
Researchers discover how Yersinia immobilizes immune system to spread within organs

Researchers discover how Yersinia immobilizes immune system to spread within organs

​Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection. [More]
Hospital readmissions rates for children are not meaningful measures of quality of their care

Hospital readmissions rates for children are not meaningful measures of quality of their care

Readmission rates of adult patients to the same hospital within 30 days are an area of national focus and a potential indicator of clinical failure and unnecessary expenditures. [More]
Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

Researchers to examine effectiveness of antibiotic therapy to treat appendicitis in children

In the first study of its kind in the United States, researchers at Nationwide Children's Hospital will examine the effectiveness of antibiotic therapy alone to treat appendicitis in children, research that could allow patients to avoid a surgery many may not need. [More]
Hospital type plays a role in racial disparities and appendicitis outcomes in children

Hospital type plays a role in racial disparities and appendicitis outcomes in children

When researchers from UCLA Medical Center investigated the link between racial disparities and appendicitis outcomes in children, they found that the type of hospital in which black, Hispanic and other minority patients receive care-community, children's or county-affects their odds of developing a perforated appendix. The study published in the January issue of the Journal of the American College of Surgeons is a first-of-its-kind look at the role hospital type plays in race-based treatment variances among this patient subset. [More]
Bumping up appendicitis diagnostic accuracy

Bumping up appendicitis diagnostic accuracy

It is well worth emergency doctors asking patients with abdominal pain how they were affected by driving over speed bumps on their way to hospital, research suggests. [More]
Use of CT scans for children suspected of having appendicitis varies among hospitals

Use of CT scans for children suspected of having appendicitis varies among hospitals

Children suspected of having appendicitis are more likely to receive CT scans, which involve radiation, if they are evaluated at a general hospital, a new study by Washington University School of Medicine in St. Louis has shown. [More]

Venaxis seeks CE Mark approval for blood-based appendicitis test

Venaxis, Inc., an in vitro diagnostic company, today announced it has filed for CE Mark approval in Europe for APPY1, the Company's blood-based appendicitis test. [More]
Proteins detected in urine may enable diagnosis of Kawasaki disease

Proteins detected in urine may enable diagnosis of Kawasaki disease

A set of proteins detected in urine by researchers at Boston Children's Hospital may prove to be the first biomarkers for Kawasaki disease, an uncommon but increasingly prevalent disease which causes inflammation of blood vessels that can lead to enlarged coronary arteries and even heart attacks in some children. [More]

AspenBio Pharma closes underwritten public offering of 1,946,000 shares of common stock

AspenBio Pharma, Inc., an in vitro diagnostic company, today announced the closing of an underwritten public offering of 1,946,000 shares of common stock at an offering price of $2.10 per share. [More]